Evolve Biosystems: Evolve BioSystems announces investment from Cargill and Manna Tree for infant gut health probiotic
US microbiome company Evolve BioSystems has announced that it completed a first close in a $55m Series D round of funding, led by Cargill, the global food, agricultural, financial and industrial products company and Manna Tree, an investment firm committed to improving human health.
Read full article »
CEO
Evolve Biosystems is a California-based biotechnology firm that develops and commercializes microbiome-based therapeutics for the treatment of infant gut health problems.
Read more